6-benzylthioinosine

 

Topic mentions per year

Topic mentions per year

1975-2016
01219752016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Current therapy for acute myeloid leukemia (AML) primarily includes high-dose cytotoxic chemotherapy with or without allogeneic… (More)
Is this relevant?
2014
2014
We previously demonstrated that 6-benzylthioinosine (6-BT) could induce the differentiation of a subset of acute myeloid leukemia… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Carbocyclic 6-benzylthioinosine analogues were synthesized and evaluated for their binding affinity against Toxoplasma gondii… (More)
Is this relevant?
2010
2010
Toxoplasma gondii adenosine kinase (EC 2.7.1.20) is the major route of adenosine metabolism in this parasite. The enzyme is… (More)
Is this relevant?
2008
2008
As the pathophysiology of acute myelogenous leukemia (AML) involves a block of myeloid maturation, a desirable therapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Toxoplasma gondii adenosine kinase (EC.2.7.1.20) is the major route of adenosine metabolism in this parasite. The enzyme is… (More)
Is this relevant?
2005
2005
Toxoplasma gondii adenosine kinase (EC.2.7.1.20) is the major route of adenosine metabolism in this parasite. The enzyme is… (More)
Is this relevant?
2005
2005
Certain 6-benzylthioinosine analogues have been identified as potential chemotherapeutic agents against Toxoplasma gondii in cell… (More)
Is this relevant?
2004
2004
Toxoplasma gondii is the most common cause of secondary CNS infections in immunocompromised persons such as AIDS patients. The… (More)
Is this relevant?
1999
1999
The purine nucleoside analogue NBMPR (nitrobenzylthioinosine or 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine) was… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?